Skip to main content

Free Content Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary

Objective  A recent randomized clinical trial demonstrated home‐based treatment of WHO‐defined severe pneumonia with oral amoxicillin was equivalent to hospital‐based therapy and parenteral antibiotics. We aimed to determine whether this finding is generalizable across four countries.

Methods  Multicentre observational study in Bangladesh, Egypt, Ghana and Vietnam between November 2005 and May 2008. Children aged 3–59 months with WHO‐defined severe pneumonia were enrolled at participating health centres and managed at home with oral amoxicillin (80–90 mg/kg per day) for 5 days. Children were followed up at home on days 1, 2, 3 and 6 and at a facility on day 14 to look for cumulative treatment failure through day 6 and relapse between days 6 and 14.

Results  Of 6582 children screened, 873 were included, of whom 823 had an outcome ascertained. There was substantial variation in presenting characteristics by site. Bangladesh and Ghana had fever (97%) as a more common symptom than Egypt (74%) and Vietnam (66%), while in Vietnam, audible wheeze was more common (49%) than at other sites (range 2–16%). Treatment failure by day 6 was 9.2% (95% CI: 7.3–11.2%) across all sites, varying from 6.4% (95% CI: 3.1–9.8%) in Ghana to 13.2% (95% CI: 8.4–18.0%) in Vietnam; 2.7% (95% CI: 1.5–3.9%) of the 733 children well on day 6 relapsed by day 14. The most common causes of treatment failure were persistence of lower chest wall indrawing (LCI) at day 6 (3.8%; 95% CI: 2.6–5.2%), abnormally sleepy or difficult to wake (1.3%; 95% CI: 0.7–2.3%) and central cyanosis (1.3%; 95% CI: 0.7–2.3%). All children survived and only one adverse drug reaction occurred. Treatment failure was more frequent in young infants and those presenting with rapid respiratory rates.

Conclusions  Clinical treatment failure and adverse event rates among children with severe pneumonia treated at home with oral amoxicillin did not substantially differ across geographic areas. Thus, home‐based therapy of severe pneumonia can be applied to a wide variety of settings.

Language: English

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1365-3156.2011.02787.x

Affiliations: 1:  Komfo Anokye Teaching Hospital, University of Science and Technology, Kumasi, Ghana 2:  National Institute of Hygiene and Epidemiology, Hanoi, Vietnam 3:  Department of Pediatrics and Clinical Epidemiology, Suez Canal University, Ismailia, Egypt 4:  Center for Global Health and Development, Boston University, Boston, MA, USA 5:  Dhaka Shishu Hospital, Dhaka, Bangladesh 6:  Respiratory Department, Children’s Hospital No. 1, Ho Chi Minh City, Vietnam 7:  Department of Child and Adolescent Health and Development, WHO, Geneva, Switzerland

Publication date: 2011-08-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more